亲爱的研友该休息了!由于当前在线用户较少,发布求助请尽量完整地填写文献信息,科研通机器人24小时在线,伴您度过漫漫科研夜!身体可是革命的本钱,早点休息,好梦!

Safety and preliminary efficacy of argatroban plus dual antiplatelet therapy for acute mild to moderate ischemic stroke with large artery atherosclerosis

医学 阿加曲班 改良兰金量表 冲程(发动机) 内科学 前瞻性队列研究 心脏病学 缺血性中风 缺血 机械工程 血小板 工程类 凝血酶
作者
Xiaoqiu Li,Xiaowen Hou,Yu Cui,Xiao-Fu Tian,Xinhong Wang,Zhonghe Zhou,Hui‐Sheng Chen
出处
期刊:Brain and behavior [Wiley]
卷期号:12 (7) 被引量:1
标识
DOI:10.1002/brb3.2664
摘要

Previous studies suggest the benefit of dual antiplatelet therapy (DAPT) for acute ischemic stroke with large artery atherosclerosis (LAA) etiology, but there is no study about the effect of DAPT plus anticoagulant in this population.A prospective single arm trial was performed to determine the effect of DAPT combined with argatroban on acute mild to moderate ischemic stroke patients with LAA, which was compared with historical populations. The main outcome was the proportion of early neurological deterioration (END). The secondary outcomes included scores of 0 to 1 and 0 to 2 on the modified Rankin Scale (mRS) at 90 days, and changes in National Institutes of Health Stroke Scale (NIHSS) from baseline to day 7 after admission. The safety outcomes included intracranial hemorrhage at 7 days, organ hemorrhage, and all-cause mortality at 90 days.A total of 120 patients with argatroban plus DAPT were prospectively enrolled and 529 patients with only DAPT were retrospectively collected. There was no significant difference in baseline characteristics between groups. Compared with control group, combined treatment group had lower proportion of END (4.2% vs. 10.0%, adjusted p = .046), more reduction in NIHSS score from the baseline to day 7 after admission (1.06 ± 2.03 vs. 0.39 ± 1.97, adjusted p = .003), and higher proportion of mRS (0-2) at 90 days (87.5% vs. 79.2%, adjusted p = .048). No intracranial hemorrhage was found between groups.This is the first report that short-term argatroban combined with DAPT seems to be safe and may effectively prevent END and improve neurological prognosis for acute mild to moderate ischemic stroke patients with LAA; however, interpretation of the conclusion required caution due to nonrandomized controlled trial with medium sample size.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
madeleinli的应助被rsdhhrds采纳,获得10
刚刚
madeleinli的应助被rsdhhrds采纳,获得10
9秒前
无花果的应助被suuuye采纳,获得30
9秒前
9秒前
杭子轩发布了新的文献求助10
13秒前
14秒前
上官若男的应助被accept采纳,获得10
15秒前
苹果梦蕊完成签到 ,获得积分10
16秒前
无私的莫言完成签到,获得积分10
16秒前
随缘完成签到 ,获得积分10
16秒前
我与我周旋久完成签到 ,获得积分10
18秒前
小兔兔猎魊完成签到,获得积分10
18秒前
18秒前
madeleinli的应助被rsdhhrds采纳,获得10
20秒前
21秒前
杭子轩完成签到,获得积分10
24秒前
24秒前
accept发布了新的文献求助10
25秒前
欢喜的诗珊完成签到,获得积分10
30秒前
英俊鼠标完成签到 ,获得积分10
32秒前
洪亮发布了新的文献求助10
33秒前
34秒前
35秒前
Atlantis30发布了新的文献求助10
40秒前
41秒前
情怀的应助被祈文采纳,获得10
48秒前
CRUSADER完成签到,获得积分10
48秒前
顾芷萌完成签到 ,获得积分10
49秒前
wejcxl完成签到,获得积分10
56秒前
57秒前
chenchen完成签到,获得积分10
1分钟前
科研通AI6.3的应助被洪亮采纳,获得30
1分钟前
1分钟前
1分钟前
小孙完成签到,获得积分10
1分钟前
李李发布了新的文献求助10
1分钟前
1分钟前
何靖完成签到 ,获得积分20
1分钟前
1分钟前
1分钟前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1700
The World Atlas of Wine 9th edition 1000
奈特基础组织学:配套组织病理学(第4版)(Netter's Essential Histology With Correlated Histopathology) 800
John McDowells Bildungstheorie 800
Social Psychology in the Real World 600
八旗制度の研究 600
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8179747
求助须知:如何正确求助?哪些是违规求助? 9569953
关于积分的说明 21807937
捐赠科研通 7775354
什么是DOI,文献DOI怎么找? 3433080
关于科研通互助平台的介绍 2557157
邀请新用户注册赠送积分活动 2478806